Concepedia

Publication | Open Access

Comparative biochemical kinase activity analysis identifies rivoceranib as a highly selective VEGFR2 inhibitor

DOIFull Paper Access

10

Citations

16

References

2023

Year

Seong Jang, Bill Strickland, Lynda Finis, Jeffrey J. Kooijman, Janneke J. T. M. Melis, Guido J.R. Zaman, Jan Van Tornout
Cancer Chemotherapy and Pharmacology

References

YearCitations

Page 1